|
0
|
|
Safety, immunovirological, and CNS effects of PD-1 inhibition in people with HIV without malignancy.
(academic.oup.com)
|
Reoma LB
…
Nath A
Journal of Infectious Diseases
2026-03-06
|
#immunity
#immunotherapy
#cns
#hiv
|
|
0
|
|
Lactobacillus reuteri SKLAN202402ZF inhibited by early-life lincomycin exposure alleviate intestinal damage and inflammation sensitivity.
(link.springer.com)
|
Zhang S
…
Zhang H
Microbiome
2026-03-06
|
#microbiome
#immunity
#dysbiosis
#inflammation
#probiotic
|
|
0
|
|
Coeliac disease and the intestinal barrier: mechanisms of disruption and strategies for restoration.
(gut.bmj.com)
|
Damianos JA
…
Murray JA
Gut
2026-03-06
|
#immunity
#dysbiosis
#inflammation
#barrier
#celiac
|
|
0
|
|
PD-1 blockade promotes mucosal CD4+ T cell IL-10 production through altering microbiota to reduce intestinal ischemia reperfusion injury.
(tandfonline.com)
|
Wen SH
…
Zhang XY
Gut Microbes
2026-03-06
|
#microbiome
#metabolism
#immunity
#inflammation
#immunotherapy
|
|
0
|
|
Spatial transcriptomics defines the molecular progression, invasion and immune landscape of IPMN and IPMN-derived pancreatic cancer.
(gut.bmj.com)
|
Cui M
…
Zhao Y
Gut
2026-03-06
|
#immunity
#transcriptomics
#pancreatic cancer
#precancerous
|